Can marijuana laced chewing gum treat irritable bowel syndrome? | health and fitness | Hindustan Times
Today in New Delhi, India
Mar 23, 2017-Thursday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Can marijuana laced chewing gum treat irritable bowel syndrome?

A study suggests that a chewing gum laced in cannabis can cure irritable bowel syndrome, reducing painful stomach cramps, control bloating and normalise stool.

health and fitness Updated: Mar 15, 2017 08:29 IST
ANI
marijuana

Researchers from Wageningen University in the Netherlands claims CBD - a key property in marijuana - could ease the colon spasms that seem to be the root cause of symptoms.(Shutterstock)

A study suggests that a chewing gum laced in cannabis can cure irritable bowel syndrome, reducing painful stomach cramps, control bloating and normalise stool.

Researchers from Wageningen University in the Netherlands claims CBD - a key property in marijuana - could ease the colon spasms that seem to be the root cause of symptoms, reports Dailymail.

“We are excited to see that Axim Biotechnologies Inc (AXIM) has reached another milestone in its clinical development program,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc.

“This is the first advancement in cannabinoid research for treatment of IBS in medical history and gives a clear example of how far ahead AXIM is in its clinical development programs,” Titus added.

The study claims itself to be first of its kind to test a relationship between CBD and IBS.

Read more


From next month, the trial will begin, testing a cannabis-infused chewing gum made by US firm Medical Marijuana Inc.

They will give trial to 40 participants, aged between 18 and 65, alongside matching placebo gums.

The gum will contain 50mg of CBD per serving and the participants will be allowed up to six chewing gums a day to control their stomach cramps, bloating, pain and other symptoms.

Preliminary research suggests the product could reduce painful stomach cramps, control bloating, and normalize stool.

“The cost to society in terms of direct medical expenses and indirect costs associated with loss of productivity and work absenteeism tied to IBS is considerable,” Dr Titus stated.

The study reveals that the drug would interact with the endogenous cannabinoid receptors in sufferers’ digestive tract, loosening tension.

Specifically, it will test a new product called CanChew, developed my AXIM Biotechnologies, Medical Marijuana Inc’s major investment company.